Source: Annual Congress 2003 - Cystic fibrosis: basic science to clinical context
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. De Soyza, J. Perry, C. M. A. Khan, P. A. Corris (Newcastle, United Kingdom). Phenotypic assessment of potential Burkholderia cepacia virulence associated determinants. Eur Respir J 2003; 22: Suppl. 45, 3150

Member's Comments

No comment yet.

Related content which might interest you: The role of MBL in B. cepacia infections in CF patients Source: Eur Respir J 2005; 26: Suppl. 49, 403s Year: 2005 Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD. Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 The relevance of epidemic ET-12 B. cenocepacia lipopolysaccharide (LPS) structure and cytokine induction capacity compared to other burkholderia cepacia complex species Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018 Antimicrobial activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and in biofilm Source: International Congress 2017 – How can microbiology and translational research help physicians? Year: 2017 Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients Source: Eur Respir J 2004; 23: 851-856 Year: 2004 Proteomics based investigations of burkholderia cepacia complex species Source: Eur Respir J 2006; 28: Suppl. 50, 327s Year: 2006 Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Burkholderia cepacia complex infection in Czech patients with cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 503s Year: 2003 TNF and LTA gene polymorphisms in cystic fibrosis patients with Burkholderia cepacia complex (Bcc) Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021 Uncommon accumulation of multidrug resistance and virulence potential in carbapenemase ST-14 KPC-3 Klebsiella pneumoniae in Portugal: a high risk threat Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit Year: 2018 Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Host response to transmissible Pseudomonas aeruginosa Source: Eur Respir J 2004; 23: 493-494 Year: 2004 Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 Clinical and microbiological characteristics of Pseudomonas aeruginosa isolates from patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 58s Year: 2005 Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017 Year: 2018